FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947236489> ?p ?o ?g. }

• W2947236489 endingPage "202" @default.
• W2947236489 startingPage "194" @default.
• W2947236489 abstract "Objectives Assess outcomes of a clinical cohort of patients with endometrioid endometrial cancer (EEC) harboring somatic POLE exonuclease domain mutations (EDMs). Methods Patients were consented to a protocol of tumor-normal massively parallel sequencing of 410–468 cancer related genes. EECs subjected to sequencing from 2014 to 2018 were reviewed. Tumors with somatic POLE EDMs were identified. EECs were assessed for microsatellite instability (MSI) using MSIsensor and immunohistochemical analysis for mismatch repair (MMR) proteins. Results Of the 451 EECs sequenced, 23 had a POLE EDM (5%): 20 primary and 3 recurrent tumors sequenced. Nineteen cases (83%) were stage I/II and 4 (17%) were stages III/IV. Thirteen EECs (57%) were of FIGO grades 1/2, 10 (43%) grade 3. All patients were treated with surgery and 17 (89%) received adjuvant therapy. Five (22%) demonstrated loss of DNA MMR protein expression, none were due to Lynch syndrome. MSIsensor scores were conclusive for 21 samples: 19 were microsatellite stable and 2 MSI-high. After median follow-up of 30 months, 4/23 (17%) developed recurrences: 3 with initial grade 3 stage I and 1 with grade 1 stage III disease. One patient with grade 2 stage IV EEC had progressive disease after treatment. Conclusions Patients with POLE EDM EEC have been shown to have a favorable prognosis. In this real-world cohort of patients, de novo metastatic disease and recurrences in initially uterine-confined cases were observed. Further research is warranted before incorporating the presence of POLE EDM into decision-making regarding adjuvant therapy." @default.
• W2947236489 created "2019-06-07" @default.
• W2947236489 creator A5002011120 @default.
• W2947236489 creator A5002626635 @default.
• W2947236489 creator A5004706727 @default.
• W2947236489 creator A5020579694 @default.
• W2947236489 creator A5023685848 @default.
• W2947236489 creator A5024954765 @default.
• W2947236489 creator A5025321281 @default.
• W2947236489 creator A5033305052 @default.
• W2947236489 creator A5040506127 @default.
• W2947236489 creator A5046956876 @default.
• W2947236489 creator A5050336579 @default.
• W2947236489 creator A5053542215 @default.
• W2947236489 creator A5054602117 @default.
• W2947236489 creator A5065147515 @default.
• W2947236489 creator A5068193017 @default.
• W2947236489 creator A5072735395 @default.
• W2947236489 creator A5074877517 @default.
• W2947236489 creator A5081307135 @default.
• W2947236489 creator A5085163128 @default.
• W2947236489 date "2020-01-01" @default.
• W2947236489 modified "2023-10-06" @default.
• W2947236489 title "Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer" @default.
• W2947236489 cites W1630303999 @default.
• W2947236489 cites W1981507269 @default.
• W2947236489 cites W2011575493 @default.
• W2947236489 cites W2041440766 @default.
• W2947236489 cites W2059184834 @default.
• W2947236489 cites W2101810235 @default.
• W2947236489 cites W2110037976 @default.
• W2947236489 cites W2114843025 @default.
• W2947236489 cites W2117564738 @default.
• W2947236489 cites W2121356457 @default.
• W2947236489 cites W2146501164 @default.
• W2947236489 cites W2152061559 @default.
• W2947236489 cites W2238237545 @default.
• W2947236489 cites W223909586 @default.
• W2947236489 cites W2276335691 @default.
• W2947236489 cites W2329869296 @default.
• W2947236489 cites W2343491564 @default.
• W2947236489 cites W2383119765 @default.
• W2947236489 cites W2437736820 @default.
• W2947236489 cites W2481467115 @default.
• W2947236489 cites W2554756829 @default.
• W2947236489 cites W2613362156 @default.
• W2947236489 cites W2753565653 @default.
• W2947236489 cites W2758034116 @default.
• W2947236489 cites W2773354488 @default.
• W2947236489 cites W2793962581 @default.
• W2947236489 cites W2794053055 @default.
• W2947236489 cites W2896564105 @default.
• W2947236489 cites W2898473996 @default.
• W2947236489 cites W2900288204 @default.
• W2947236489 cites W2911188335 @default.
• W2947236489 cites W2914487464 @default.
• W2947236489 cites W2919250255 @default.
• W2947236489 cites W2927732649 @default.
• W2947236489 doi "https://doi.org/10.1016/j.ygyno.2019.10.028" @default.
• W2947236489 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6980651" @default.
• W2947236489 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31757464" @default.
• W2947236489 hasPublicationYear "2020" @default.
• W2947236489 type Work @default.
• W2947236489 sameAs 2947236489 @default.
• W2947236489 citedByCount "28" @default.
• W2947236489 countsByYear W29472364892020 @default.
• W2947236489 countsByYear W29472364892021 @default.
• W2947236489 countsByYear W29472364892022 @default.
• W2947236489 countsByYear W29472364892023 @default.
• W2947236489 crossrefType "journal-article" @default.
• W2947236489 hasAuthorship W2947236489A5002011120 @default.
• W2947236489 hasAuthorship W2947236489A5002626635 @default.
• W2947236489 hasAuthorship W2947236489A5004706727 @default.
• W2947236489 hasAuthorship W2947236489A5020579694 @default.
• W2947236489 hasAuthorship W2947236489A5023685848 @default.
• W2947236489 hasAuthorship W2947236489A5024954765 @default.
• W2947236489 hasAuthorship W2947236489A5025321281 @default.
• W2947236489 hasAuthorship W2947236489A5033305052 @default.
• W2947236489 hasAuthorship W2947236489A5040506127 @default.
• W2947236489 hasAuthorship W2947236489A5046956876 @default.
• W2947236489 hasAuthorship W2947236489A5050336579 @default.
• W2947236489 hasAuthorship W2947236489A5053542215 @default.
• W2947236489 hasAuthorship W2947236489A5054602117 @default.
• W2947236489 hasAuthorship W2947236489A5065147515 @default.
• W2947236489 hasAuthorship W2947236489A5068193017 @default.
• W2947236489 hasAuthorship W2947236489A5072735395 @default.
• W2947236489 hasAuthorship W2947236489A5074877517 @default.
• W2947236489 hasAuthorship W2947236489A5081307135 @default.
• W2947236489 hasAuthorship W2947236489A5085163128 @default.
• W2947236489 hasBestOaLocation W29472364892 @default.
• W2947236489 hasConcept C104317684 @default.
• W2947236489 hasConcept C121608353 @default.
• W2947236489 hasConcept C126322002 @default.
• W2947236489 hasConcept C13514818 @default.
• W2947236489 hasConcept C143998085 @default.
• W2947236489 hasConcept C146357865 @default.
• W2947236489 hasConcept C151730666 @default.
• W2947236489 hasConcept C180754005 @default.

• next